Entering text into the input field will update the search result below

Premarket analyst action - upgrades

Jan. 06, 2017 8:29 AM ETGlaukos Corporation (GKOS) StockTVTY, IART, PODD, LRMR, GKOSBy: Douglas W. House, SA News Editor
  • Glaukos (NYSE:GKOS) upgraded to Buy with $45 (34% upside) price target by Stifel Nicolaus.
  • Healthways (HWAY) upgraded to Buy with a $29 (25% upside) price target by Jefferies.
  • Insulet (NASDAQ:PODD) upgraded to Outperform with $47 (27% upside) price target by Baird.
  • Integra LifeSciences (NASDAQ:IART) upgraded to Market Outperform with $50 (16% upside) price target by JMP Securities.
  • Zafgen (NASDAQ:ZFGN) upgraded to Market Outperform with $8 (139% upside) price target by JMP Securities.

Recommended For You

More Trending News

About GKOS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
GKOS--
Glaukos Corporation
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.